Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,361 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Active, Not Recruiting

IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

NCT03744390

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Hôpital André Mignot Versailles, LE Chesnay, France
  • CHU Montpellier St Eloi Montpellier, France
  • CH d'Angers/Service des Maladies du sang Angers, France
  • centre hospitalier Victor Dupouy Argenteuil, France
View all 22 locations
View Trial Details
Active, Not Recruiting

IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome

NCT03503409

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • CH Angers Angers, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • Hôpital Nord Franche-Comté/Service de médecine interne / Hématologie clinique Belfort, France
  • CHU côte de Nacre Caen, France
View all 38 locations
View Trial Details
Active, Not Recruiting

Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

NCT04232241

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Bone Marrow Diseases, +14 more
Locations
  • LKH-Univ. Klinikum Graz Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Medizinische Universität Wien, Universitätsklinik für Innere Medizin I Einrichtung für Stammzelltransplantation KMT Vienna, Austria
  • Institute of Hematology and Blood Transfusion Prague, Czechia
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

NCT05883956

Conditions
Behavior, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Townsville Hospital Townsville, Queensland, Australia
  • Adelaide Oncology and Haematology North Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

NCT04623944

Conditions
AML, Adult, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

NCT03682536

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +4 more
Locations
  • Local Institution - 107 Berkeley, California, United States
  • Local Institution - 115 San Diego, California, United States
  • Local Institution - 101 Whittier, California, United States
  • Local Institution - 104 New Haven, Connecticut, United States
View all 226 locations
View Trial Details

Related conditions